The Shotlee Journal
Browse Shotlee articles about Metabolic Health.
Showing 9 / 744 Metabolic Health articles
Glenmark Pharmaceuticals is gearing up to launch affordable versions of semaglutide, the blockbuster GLP-1 drug for diabetes and obesity, later this month. This move intensifies competition among Indian drugmakers like Sun Pharma and Dr Reddy's following the March 21 patent expiry. With prices potentially half those of innovators, millions of patients stand to gain better access.
New research from the University of Toronto reveals that older adults with diabetes taking semaglutide (Ozempic and Wegovy) face more than double the risk of neovascular age-related macular degeneration (nAMD), a severe form of vision loss. The study, published in JAMA Ophthalmology, highlights increased risks with longer use and certain comorbidities. Patients should prioritize regular eye exams to catch issues early.
A new Leger Healthcare survey estimates that around three million Canadian adults are currently using GLP-1 medications such as Ozempic or Mounjaro. These drugs are not only curbing appetite and cravings but also transforming daily spending habits, from less restaurant takeout to more fresh produce and gym memberships. Weight loss tops the reasons, but barriers like cost keep millions from starting.
Kelly Osbourne's poignant BRIT Awards 2026 appearance alongside Sharon Osbourne sparked a wave of concerned and harsh comments about her dramatic weight loss. Labeled a 'walking skeleton' and accused of Ozempic use, the star hit back on Instagram against the cruelty amid her family's grief. Learn about her defense and the ongoing body shaming she faces.
Donna Kelce, mother of NFL stars Travis and Jason, is clapping back at online speculation that her slimmer figure on The Traitors came from weight-loss drugs like Ozempic. The 73-year-old reveals she lost about 30 pounds over a year through intermittent fasting alone. Her story highlights natural paths to metabolic health amid GLP-1 hype.
RFK Jr. revealed on the Joe Rogan Experience his intent to lift FDA restrictions on 14 banned peptides from compounding pharmacies. This reversal addresses the late 2023 Category 2 list ban amid safety concerns and black market shifts. Patients and wellness advocates await formal decisions in coming weeks.
While Ozzy Osbourne received a posthumous lifetime achievement award at the Brit Awards, online focus shifted to Kelly Osbourne's appearance with cruel comments. In an emotional Instagram post, Kelly called out the lack of compassion during her hardest time. This echoes prior backlash accusing her of Ozempic use amid grief.
Kelly Osbourne addressed viral body-shaming after the Brit Awards, where critics mocked her slim figure and urged her to 'get off Ozempic.' Revealing she's enduring her hardest time after Ozzy Osbourne's death, she called out the lack of compassion. Her mother Sharon defended her, highlighting grief's toll on eating.
Urban India faces a metabolic crisis with 73 million overweight adults, yet GLP-1 therapy awareness hovers below 5%, per Kantar's latest report. Despite high weight loss intent, a stark knowledge gap limits adoption of these diabetes and obesity treatments. Explore the data, demographics, and paths forward for better metabolic health.
